We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
皇冠体育app locations for a Marketing Authorisation Holder (MAH) and a Qualified Person responsible for Pharmacovigilance (QPPV)
Apply for and maintain registrations for the brokering of human medicines.
Reporting, investigating and recalling suspected defective medicinal products to the Defective Medicines Report Centre (DMRC).
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Approved countries for batch testing and importation of medicines
Guidance on the steps manufacturers and suppliers can take to ease supply shortages.
This guide has been provided to reduce the burden when preparing responses to Post Inspection Letters.
How manufacturers can apply for approval to supply a non-compliant medical device on humanitarian grounds.
皇冠体育app EU has published guidance on exemptions for medical devices manufactured and used within EU health institutions, which applies to Northern Ireland-based health institutions, replacing interim guidance from the MHRA.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Supplementary information for international regulators on packaging changes and the export of UK medicines.
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
How the 鈥榃ritten Confirmation鈥� process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
On this page the Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
summary
Guidance on moving medicines by air
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we鈥檇 like to know more about your visit today. .